David Scott
Cited by
Cited by
Immunogenicity of protein therapeutics
AS De Groot, DW Scott
Trends in immunology 28 (11), 482-490, 2007
Activation of natural regulatory T cells by IgG Fc–derived peptide “Tregitopes”
AS De Groot, L Moise, JA McMurry, E Wambre, L Van Overtvelt, ...
Blood, The Journal of the American Society of Hematology 112 (8), 3303-3311, 2008
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
RA Maldonado, RA LaMothe, JD Ferrari, AH Zhang, RJ Rossi, PN Kolte, ...
Proceedings of the National Academy of Sciences 112 (2), E156-E165, 2015
Activation-induced apoptosis in lymphocytes
DR Green, DW Scott
Current opinion in immunology 6 (3), 476-487, 1994
Death the Fas way: regulation and pathophysiology of CD95 and its ligand
K Sharma, RX Wang, LY Zhang, DL Yin, XY Luo, JC Solomon, RF Jiang, ...
Pharmacology & therapeutics 88 (3), 333-347, 2000
Regulation of the G1 phase of the mammalian cell cycle
D Donjerkovic, DW Scott
Cell research 10 (1), 1-16, 2000
Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins
TC Lei, DW Scott
Blood 105 (12), 4865-4870, 2005
Engineered antigen-specific human regulatory T cells: immunosuppression of FVIII-specific T-and B-cell responses
YC Kim, AH Zhang, Y Su, SA Rieder, RJ Rossi, RA Ettinger, KP Pratt, ...
Blood, The Journal of the American Society of Hematology 125 (7), 1107-1115, 2015
FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T-and B-cell responses to FVIII
J Yoon, A Schmidt, AH Zhang, C Königs, YC Kim, DW Scott
Blood, The Journal of the American Society of Hematology 129 (2), 238-245, 2017
Tregitope update: mechanism of action parallels IVIg
LP Cousens, R Tassone, BD Mazer, V Ramachandiran, DW Scott, ...
Autoimmunity Reviews 12 (3), 436-443, 2013
Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu.
DW Scott, D Livnat, CA Pennell, P Keng
The Journal of experimental medicine 164 (1), 156-164, 1986
Lymphoma models for B cell activation and tolerance. X. Anti-mu-mediated growth arrest and apoptosis of murine B cell lymphomas is prevented by the stabilization of myc.
G Fischer, SC Kent, L Joseph, DR Green, DW Scott
The Journal of experimental medicine 179 (1), 221-228, 1994
Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis
RK Agarwal, Y Kang, E Zambidis, DW Scott, CC Chan, RR Caspi
The Journal of clinical investigation 106 (2), 245-252, 2000
Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases
MEF Melo, J Qian, M El-Amine, RK Agarwal, N Soukhareva, Y Kang, ...
The Journal of Immunology 168 (9), 4788-4795, 2002
In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity
LP Cousens, N Najafian, F Mingozzi, W Elyaman, B Mazer, L Moise, ...
Journal of clinical immunology 33, 43-49, 2013
Activation-induced cell death in B lymphocytes
Cell Research 10 (3), 179-192, 2000
Role of IgD in the immune response and tolerance. I. Anti-delta pretreatment facilitates tolerance induction in adult B cells in vitro.
DW Scott, JE Layton, GJ Nossal
The Journal of experimental medicine 146 (6), 1473-1483, 1977
T cells commit suicide, but B cells are murdered!
DW Scott, T Grdina, Y Shi
Journal of immunology (Baltimore, Md.: 1950) 156 (7), 2352-2356, 1996
Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes
DM Brown, GL Warner, JE Alés-Martínez, DW Scott, RP Phipps
Clinical immunology and immunopathology 63 (3), 221-229, 1992
Epitope-specific tolerance induction with an engineered immunoglobulin.
ET Zambidis, DW Scott
Proceedings of the National Academy of Sciences 93 (10), 5019-5024, 1996
The system can't perform the operation now. Try again later.
Articles 1–20